Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) vs qXR-CTR
AI Verdict
Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…
Choose the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) if you require continuous, real-time heart rhythm monitoring and the immediate treatment of life-threatening arrhythmias for patients in an outpatient setting. This water-resistant, patch-based device is ideal for individuals needing high compliance and discreet wear, providing both detection and therapy through its machine learning algorithm. It's best suited for active management of patients at risk of sudden cardiac events who need a wearable defibrillation solution.
View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →Choose qXR-CTR if…
Choose qXR-CTR if your clinical workflow requires automated, rapid assessment of heart size from standard chest X-ray images to screen for potential heart failure risk. This AI-powered software is particularly useful in radiology departments or primary care settings where quick, objective measurements of the cardiothoracic ratio (CTR) can aid in early detection and risk stratification. It streamlines the diagnostic process by providing an efficient, consistent method for evaluating cardiac enlargement.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) | qXR-CTR |
|---|---|---|
| Deployment | Wearable device with mobile app | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)Tool A, the Jewel Patch, demonstrates superior patient usability through its discreet, water-resistant, patch-based design, which significantly enhances patient comfort and compliance. Clinical studies show a high median wear time of over 23 hours per day, indicating its seamless integration into patients' daily lives.
Clinical Value
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)Tool A provides direct, life-saving intervention by continuously monitoring for and treating life-threatening arrhythmias, with documented successful conversions and no deaths due to non-compliance in its pivotal study. Tool B, while valuable, serves as a diagnostic aid for assessing heart failure risk, which is a less immediate and direct clinical intervention.
Pricing & Value
TieBoth Tool A and Tool B explicitly state that their pricing information is not publicly available and requires direct contact with the vendor. Without any disclosed pricing details or comparative cost-effectiveness analyses, it is impossible to determine which offers better pricing or overall value.
Enterprise Readiness
qXR-CTRTool B offers flexible deployment options including cloud, on-premise, and hybrid, which is a significant advantage for integrating software into diverse enterprise healthcare IT infrastructures. While Tool A has FDA clearance and associated digital platforms are expected to be HIPAA compliant, Tool B's deployment flexibility for a software solution enhances its readiness for varied enterprise environments.
Innovation
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)Tool A represents a more groundbreaking innovation by introducing a patch-based, water-resistant wearable cardioverter defibrillator, addressing long-standing patient compliance issues with traditional WCDs. While Tool B utilizes AI for automated diagnostic measurements, Tool A's core product is a novel medical device design that significantly shifts the paradigm for temporary sudden cardiac arrest protection.
Support & Docs
qXR-CTRQure.ai (Tool B) demonstrates more explicit and robust support infrastructure, with multiple global office locations and customer testimonials specifically mentioning dedicated 'after sales services' and responsive teams. Element Science (Tool A) provides general contact information, but detailed support and documentation resources are less clearly articulated.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) | qXR-CTR |
|---|---|---|
| Name | Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) | qXR-CTR |
| Company | Element Science, Inc. | Qure.ai Technologies |
| Primary Function | Water-resistant, patch-based device with machine learning for continuous heart monitoring and treatment of life-threatening arrhythmias. | AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology | Cardiology, Radiology |
| Key Technology | Patch-based wearable cardioverter defibrillator with machine learning detection algorithm. | AI-powered software for automated cardiothoracic ratio assessment from chest X-rays. |
Videos
Demos, reviews, and walkthroughs featuring Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) and qXR-CTR.